top of page

Michelle H. Cameron

Cameron, Michelle_20_crop v2.jpg

Dr. Michelle Cameron is a neurologist and a physical therapist. She combines her neurology and rehabilitation expertise in patient care, research, and teaching. Her clinical focus is treating people with multiple sclerosis (MS). Her research includes clinical trials related to falls, mobility, and the use of cannabis and cannabinoids in people living with MS, as well as related to the use of physical agents in rehabilitation. She teaches professional and lay audiences around the world in-person, virtually, and through publication, about MS, physical agents, and medical uses of cannabis and cannabinoids.


Journal Articles

Judd GI, Hildebrand AD, Goldman MD, Cameron MH. Relationship between balance confidence and social engagement in people with multiple sclerosis. Multiple Sclerosis and Related Disorders. 2022;57:103440. 


Cameron M, McMillan G, Hugos C, Hildebrand A, Judd G, Jacobs P. Free From Falls education and exercise program for reducing falls in people with multiple sclerosis: a randomized controlled trial. Multiple Sclerosis Journal. 2022;28(6):980-988.


Knowles LM, Hugos CL, Cameron MH, Haselkorn JK, Bourdette DN, Turner AP. Moderators of improvements in fatigue impact following a self-management intervention in multiple sclerosis: A secondary analysis of a randomized controlled trial. American Journal of Physical Medicine & Rehabilitation. 2022; 101(4):405-409.

Cohen J, Cameron MH, Goldman MD, Goodman AD, Miller AE, Rollins A, Llorens L, Patni R, Elfon R, Johnson R. A phase 3, double-blind, placebo-controlled efficacy and safety study of ADS-5102 (amantadine) extended-release capsules in people with multiple sclerosis and walking impairment. Multiple Sclerosis Journal. 2022;28(5):817-830.


Hildebrand A, Jacobs PG, Mosquera-Lopez C, Folsom JG, Wan E, Cameron MH. Comparing fall detection methods in people with multiple sclerosis: a prospective observational cohort study. Multiple Sclerosis and Related Disorders. 2021;56:103270.


Rice J, Hildebrand A, Spain R, Senders A, Silbermann E, Wooliscroft L, Yadav V, Bourdette D, Cameron M. A cross-sectional survey of cannabis use by people with MS in Oregon and Southwest Washington. Multiple Sclerosis and Related Disorders. 2021;55:103172.


Rice J, Hildebrand A, Waslo C, Cameron M, Jones KD. Cannabis for medical purposes: a cross-sectional analysis of health care professionals’ knowledge. Journal of the American Association of Nurse Practitioners. 2021;34(1):100-106.


Cameron MH. Physical Agents in Rehabilitation: An Evidence-Based Approach to Practice. Philadelphia, PA: W. B. Saunders Company.  6th edition 2022, also available in Spanish, Portuguese, Chinese, Japanese and Greek.


Electrical stimulation for facial paralysis

La Salle University, Oaxaca, Mexico, November 2022

Electrical stimulation for critically ill patients

Oaxaca Physical Therapy Association, November 2022

Managing spasticity in MS

Ask an MS Expert - Video presentation for National MS Society and webinar for RealTalkMS, October 2022

The multidisciplinary MS care team

Cameron M, Mitchell L, Lee-Wilk T, Hugos C

Invited presentation, Consortium of MS Centers Annual Meeting, Washington, DC, June 2022

Spasticity experience in adults with multiple sclerosis: An integrated conceptual model          

Wagner J, Cameron M, Bethoux F, Field-Fote E, Lenderking W, Zaiser E, Cutts K, Steinerman J

Presented platform at Consortium of MS Centers annual meeting, Orlando, FL. October 2021

Adapting One-on-One Rehabilitation Research to Prevent Falls in People with MS to the Virtual Environment: A COVID-19 Silver Lining

Cameron M, Hildebrand A, Serdar A, Schlimgen K, Scanlan K, Hugos C

ePoster at International Symposium on Gait and Balance in MS, Denver, CO. September 2021


Physical agents in rehabilitation

Throughout US and International


Clinical cannabis for the health care provider: Best practices           

Program co-chair and presenter

Portland, OR, 2018 & 2019

bottom of page